Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
icosapent ethyl (vascepa) (1 trial)
vitamin c (1 trial)
vitamin e (1 trial)
Disease (Phase 3)
Mental Disorders (Phase 3)
Psychotic Disorders (Phase 3)
Schizophrenia (Phase 3)
Trials (1 total)
Trial APIs (3 total)